569 filings
Page 21 of 29
424B5
OCX
Oncocyte Corporation
11 Feb 19
Prospectus supplement for primary offering
12:00am
424B5
OCX
Oncocyte Corporation
8 Feb 19
Prospectus supplement for primary offering
6:06am
424B5
OCX
Oncocyte Corporation
7 Feb 19
Prospectus supplement for primary offering
4:22pm
8-K
OCX
Oncocyte Corporation
29 Jan 19
OncoCyte Announces Successful Results of DetermaVu™ R&D Validation Study
7:00am
8-K
OCX
Oncocyte Corporation
28 Jan 19
Departure of Directors or Certain Officers
5:05pm
10-Q
2018 Q3
OCX
Oncocyte Corporation
Quarterly report
13 Nov 18
4:16pm
8-K
OCX
Oncocyte Corporation
13 Nov 18
Results of Operations and Financial Condition
4:10pm
8-K
OCX
Oncocyte Corporation
29 Oct 18
OncoCyte Completes Successful Transition to New Diagnostic Testing Platform and Initiates DetermaVu™ Development Studies
4:01pm
8-K
OCX
Oncocyte Corporation
23 Oct 18
Departure of Directors or Certain Officers
12:00am
4
Kingsley Alfred D
4 Sep 18
OncoCyte / ALFRED D KINGSLEY ownership change
12:00am
4
Arno Andrew
4 Sep 18
OncoCyte / Andrew Arno ownership change
12:00am
4
Andrews Ronald Asbury
4 Sep 18
OncoCyte / RONALD ASBURY ANDREWS ownership change
12:00am
4
Redmond Cavan M.
4 Sep 18
OncoCyte / Cavan M. Redmond ownership change
12:00am
4
Last Andrew J.
4 Sep 18
OncoCyte / Andrew J. Last ownership change
12:00am
S-8
OCX
Oncocyte Corporation
30 Aug 18
Registration of securities for employees
12:00am
8-K
OCX
Oncocyte Corporation
29 Aug 18
Departure of Directors or Certain Officers
12:00am
SC 13D/A
OCX
Oncocyte Corporation
22 Aug 18
OncoCyte Corp
12:00am
3
Albert P Parker
16 Aug 18
OncoCyte / Albert P Parker ownership change
9:34pm
8-K
OCX
Oncocyte Corporation
14 Aug 18
OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate Developments
12:00am
10-Q
2018 Q2
OCX
Oncocyte Corporation
Quarterly report
14 Aug 18
12:00am